The agency launched Elsa 4.0, an upgrade to the agency’s internal AI tool available to all FDA staff, from scientific ...
Ensuring that proven therapies can be delivered safely and accessibly to the patients who need them provides opportunity in ...
PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities, according to the ...
In healthcare, a cyber vulnerability is not just an IT problem. It can quickly become a patient-care problem.” ...
FDA Commissioner Marty Makary says, one-day inspections can strengthen our inspectional approach by focusing our time and ...
Edwards announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained ...
Next generation mitral valve, designed to facilitate patient lifetime management reports first uses in sternotomy, Minimally ...
The deal would fold the FDA-cleared Hotwire system, and the team behind Farapulse, into J&J's expanding cardiac ablation ...
SUNRISE-II feasibility trial marks the company’s entry into U.S. clinical development, advancing minimally invasive, anesthesia-free treatment approach ...
The TAVVE study will begin later this year with ten patients, whose 30-day safety results will be submitted to the FDA.
Following recent FDA clearances, Medtronic is accelerating access to integrated planning, navigation, and robotics platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results